Debon Securities' Research Reports point out that Shengquan Group (605589.SH) has comprehensive advantages in synthetic Resin and is in a leading position in the Industry, maintaining a "Buy" rating for the company. In the first three quarters, both the volume and price of phenolic resin have risen, and casting resin has compensated for price with volume. Overall, the company's main Operations still maintain steady progress. In terms of biomass: After the "1 million tons/year biomass refining integrated (Phase I)" project at the Daqing production base completed renovation, capacity utilization has steadily increased, and by the end of the third quarter, the capacity utilization rate has reached over 70%. It is expected to reach full production in the fourth quarter and aims to achieve monthly breakeven by the first quarter of 2025. The company has conducted two rounds of share buybacks this year, demonstrating confidence in long-term development.
- Headlines
- Research Reports Gold Mining | Debon Securities: Maintains "Buy" rating for Shengquan Group, synthetic Resin is in an Industry leading position.
研报掘金丨德邦证券:维持圣泉集团“买入”评级,合成树脂处于行业领先地位
Research Reports Gold Mining | Debon Securities: Maintains "Buy" rating for Shengquan Group, synthetic Resin is in an Industry leading position.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Latest
12:30
"Confronting" Trump, the King of Denmark announces a new coat of arms.
12:24
Cui Dongshu from the Passenger Vehicle Association stated: "The unification of the vehicle replacement subsidy standards will make market competition more balanced across different regions."
12:21
SSY GROUP: Fumaric Acid Vonoprazan Tablets (20mg and 10mg) have received the Pharmaceutical production registration approval.
SSY GROUP-3.58%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.